Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Akermin

Explore full profile

Akermin focuses on developing commercial applications in wireless sensors for military uses

St. Louis, United StatesFounded 2004Biotechnology
Valuation $5–10M Last recorded · 2013
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Akermin and the history behind them.

About Akermin

Akermin, founded in 2003, is a company headquartered in Saint Louis, MO, that develops systems to remove carbon dioxide from industrial gases. The firm's approach integrates biocatalysts and nanotechnology, embedding enzymes into proprietary delivery systems that can be incorporated into conventional CO2 removal processes using chemical absorption. This technology is applicable to various industries that produce flue gas, such as cement production, waste-to-energy facilities, and natural gas and hydrogen production.

The company's business is centered on providing environmental services to other businesses. By focusing on a multi-disciplinary method, Akermin has developed a system that leverages biocatalysts for the efficient capture of CO2. This can be seen in their collaboration with Aker Carbon Capture, which utilizes a similar amine-based technology in projects like the one at Heidelberg Materials' Brevik cement plant in Norway. These systems work by taking flue gas and introducing it into an absorber tower, where a solvent separates the CO2. The captured CO2 is then released through a heating process, collected, and prepared for transport and storage.

Over its history, Akermin has secured significant funding to support its research and development efforts, raising a total of $22.1 million. A notable funding round occurred in January 2010, when the company raised $11.3 million in a Series B venture capital financing, bringing its total raised capital to $16.3 million at that time and reaching a revenue-generating stage.

Source: Dealroom company data

At a glance

Founded
2004
Headquarters
St. Louis, United States
Sector
Biotechnology

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Prolog Ventures
  • Chrysalix Venture Capital
  • St. Louis Arch Angels
  • OnPoint Technologies
  • Malaysian Life Sciences Capital Fund
  • Emerson Ventures
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · St. Louis HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Akermin on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Akermin on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.